Virginia Arrazubi

9PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Transgender studiesCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 17, 2026
Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study.

|Mar 17, 2026
SEOM-TTCC clinical guidelines for the treatment of head and neck cancer (2025).

Virginia Arrazubi, Lara Iglesias, Marc Oliva

|Jul 08, 2025
TTD expert consensus on emesis in gastric cancer: evidence-based strategies for prevention and treatment.

Ana Fernández Montes, Ismael Macías Declara, Nieves Martínez Lago

|May 19, 2025
A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.

Maria Alsina, Guillermo Villacampa, Carlos de Andrea

|Apr 18, 2025
Oncological needs in transgender patients.

Francisco Ayala de la Peña, David Martínez-Ramos, Oscar Juan-Vidal

|Oct 04, 2023
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer.

Virginia Arrazubi, Saioa Goñi, Iranzu González-Borja

Pageof 2

Frequent Collaborators

3 joint publications

Ruth Vera García

2 joint publications

Saioa Goñi

2 joint publications

Jairo Pérez-Sanz

2 joint publications

Hugo Arasanz